Home » Outcome of Small (10â€“20 mm) Arterial Phase-Enhancing Nodules Seen on Triphasic Liver CT in Patients with Cirrhosis or Chronic Liver Disease

TITLE

Outcome of Small (10â€“20 mm) Arterial Phase-Enhancing Nodules Seen on Triphasic Liver CT in Patients with Cirrhosis or Chronic Liver Disease

AUTHOR(S)

O'Malley, Martin E.; Takayama, Yuji; Sherman, Morris

PUB. DATE

July 2005

SOURCE

American Journal of Gastroenterology;Jul2005, Vol. 100 Issue 7, p1523

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

OBJECTIVE : To determine the outcome of small arterial phase-enhancing nodules, 10â€“20 mm, seen on serial triphasic liver CT scans in a hepatocellular cancer-screening population. METHODS : Of 58 patients referred for triphasic liver CT, 20 (18 men, 2 women) with 32 nodules formed the study group. Each patient in the study group had at least two CT scans, a minimum of 3 months follow-up, at least one nodule measuring 10â€“20 mm, no prior diagnosis of hepatocellular carcinoma, and no nodule greater than 20 mm typical of hepatocellular carcinoma at the time of the first CT. Serial CT scans were reviewed by an abdominal imaging radiologist who classified the nodules as stable, decreasing, or increasing in size. RESULTS : A mean of six CT studies (range 2â€“10) were performed for each patient with a mean follow-up of 25 months (range 4â€“47 months). Of 32 nodules, 14 (44%) were stable, 9 (28%) decreased, and 9 (28%) increased in size. Nodules that increased in size were treated as hepatocellular carcinoma: six were hepatocellular carcinoma, two were biopsy negative but showed recurrent tumor after radiofrequency ablation, and one was a high-grade dysplastic nodule. Mean doubling time for these nine nodules was 5.7 months (range 2.3â€“10.8 months). CONCLUSIONS : Most small (10â€“20 mm) arterial phase-enhancing nodules seen on triphasic liver CT are not hepatocellular carcinoma. Serial CT is useful to guide management in these patients. Growth of small arterial phase-enhancing nodules can be used as an indicator that the nodule should be treated as hepatocellular carcinoma. (Am J Gastroenterol 2005;100;1523â€“1528)

Recurrence of cancer and the need for several surgical treatments are the Achillesâ€™ heel of the treatment for hepatocellular carcinoma (HCC) in cases of cirrhosis. The difficulty of reintervention is increased by the formation of adhesions after the previous hepatectomy that can make a...

The main objective of this study is to assess the feasibility and safety of treating hepatocellular carcinoma (HCC) proximal to the gallbladder using laparoscopic radiofrequency ablation (RFA). Surgical ablation of tumor located adjacent to the gallbladder may damage the gallbladder wall, even...

OBJECTIVE: Gastrectomy might be a risk factor for cholelithiasis and gallbladder stasis might play a major role. We studied fasting and postprandial gallbladder motility with 600 mg oral erythromycin or placebo in gastrectomized patients (with and without gallstones) and controls. METHODS:...

Alterations in epithelial mucin expression are associated with carcinogenesis, but there are few data in biliary tract cancer (BTC). In pancreatic malignancy, MUC4 is a diagnostic and prognostic tumour marker, whereas MUC5AC has been proposed as a sensitive serological marker for BTC. We...

Helicobacter species have been found in human bile and biliary tract (BT) tissue and are suspected to cause BT diseases, including gallbladder and extrahepatic cancers, collectively referred to in this work as BT cancers. We conducted a literature review of the epidemiological evidence linking...

In the context of a Phase I clinical trial, the long-term vaccination of advanced biliary tract cancer patients with peptides derived from four distinct cancer-testis antigens resulted in remarkable disease stability and in the elicitation of antigenspeciic T-cell responses.

The use of radiofrequency ablation (RFA) for treatment of liver malignancies is limited by the high rate of local recurrences. The aim of this experimental study was to evaluate parameters describing the reproducible target volume of a RFA procedure in order to facilitate better applicator...

Presents a laboratory and diagnostic guide for performing a hepatobiliary imaging, which is a nuclear medicine study of the hepatobiliary excretion system. Clinical indications of hepatobiliary scan; Findings, both normal and abnormal, from hepatobiliary imaging; Contraindication of the...

Presents a laboratory and diagnostic guide for performing a hepatobiliary imaging, which is a nuclear medicine study of the hepatobiliary excretion system. Clinical indications of hepatobiliary scan; Findings, both normal and abnormal, from hepatobiliary imaging; Contraindication of the...